Philippe Moreau, MD, is Head of the Hematology Department at the University Hospital of Nantes, France. He specializes in clinical hematology, with a particular focus on multiple myeloma and its treatment with high-dose therapy and novel agents. Dr. Moreau was appointed University Professor of Clinical Hematology at Nantes Faculty of Medicine in 2003.
Prof. Moreau was a member of the organizing committee for the 2011 International Myeloma Workshop, in Paris. Prof. Moreau is currently a member of the administration council of the Intergroup Francophone du Myélome (IFM), and he was chairman of the IFM from 2006 through 2009. He is a member of the steering committee of the International Myeloma Working Group.
Prof. Moreau is widely published, with more than 250 peer-reviewed articles and reviews that have appeared in high-impact factor journals including New England Journal of Medicine, Journal of Clinical Oncology, Lancet Oncology, and Blood. He has frequently invited speakers at international hematologic oncology meetings. He is a member of the Editorial Board of the Journal of Clinical Oncology, Blood, and Blood Cancer Journal.
EVENTS & ACTIVITIES (Speaking, Spoken, and Authored)